Unique ID issued by UMIN | UMIN000009987 |
---|---|
Receipt number | R000007650 |
Scientific Title | Effects of miglitol on visceral fat distribution and cardiovascular risk factors in subjects with the metabolic syndrome |
Date of disclosure of the study information | 2013/02/08 |
Last modified on | 2018/08/13 09:21:53 |
Effects of miglitol on visceral fat distribution and cardiovascular risk factors in subjects with the metabolic syndrome
miglitol and metabolic syndrome
Effects of miglitol on visceral fat distribution and cardiovascular risk factors in subjects with the metabolic syndrome
miglitol and metabolic syndrome
Japan |
Metabolic syndrome
Endocrinology and Metabolism |
Others
NO
To clarify effects of miglitol, alpha-glucosidase inhibitor, on fat distribution and cardiovascular risk factors
Efficacy
Exploratory
Pragmatic
Not applicable
Changes in visceral fat distribution and cardiovascular risk factors
Interventional
Parallel
Randomized
Individual
Open -but assessor(s) are blinded
No treatment
2
Treatment
Medicine |
Life-style modification
Miglitol-treatment and Life-style modification
20 | years-old | <= |
80 | years-old | > |
Male and Female
Metabolic syndrome (IDF criteria). In the IDF criteria, subjects to be defined as metabolic syndrome have: abdominal obesity (modified Japanese criteria, waist circumference >=90 cm in men and >=80 cm in women), plus any two of the following four factors; 1) hypertriglyceridemia (serum triglyceride concentration >=150 mg/dl [1.69 mmol/l]); 2) low HDL cholesterol (serum HDL cholesterol concentration <40 mg/dl [1.04 mmol/l] in men and <50 mg/dl [1.29 mmol/l] in women); 3) elevated blood pressure: systolic blood pressure >=130 mmHg and/or diastolic blood pressure >=85 mmHg; 4) high fasting glucose: serum glucose concentration >=100 mg/dl (5.6 mmol/l).
Patients with a history of cardiovascular or cerebrovascular disease, hepatic or renal disease, diabetes mellitus or heavy smoker were excluded.
2
1st name | |
Middle name | |
Last name | Michio Shimabukuro, MD, PhD |
Tomishiro Chuo Hospital
Diabetes and Life-style Related Disease Center
Ueda 25, Tomishiro City, Okinawa, Japan
1st name | |
Middle name | |
Last name |
Tomishiro Chuo Hospital
Diabetes and Life-style Related Disease Center
Department of Cardio-Diabetes Medicine, The University of Tokushima Graduate School of Health Biosciences
Department of Cardio-Diabetes Medicine, The University of Tokushima Graduate School of Health Biosciences
Self funding
NO
2013 | Year | 02 | Month | 08 | Day |
Partially published
Completed
2006 | Year | 06 | Month | 30 | Day |
2006 | Year | 07 | Month | 01 | Day |
2013 | Year | 02 | Month | 07 | Day |
2018 | Year | 08 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007650
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |